| Followers | 131 |
| Posts | 15004 |
| Boards Moderated | 0 |
| Alias Born | 06/04/2018 |
Tuesday, August 06, 2019 1:40:49 PM
News: $HAE Haemonetics 1st Quarter Fiscal 2020 Earnings Release Available on Investor Relations Website
BRAINTREE, Mass. , Aug. 6, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its first quarter of fiscal 2020, which ended June 29, 2019 , are available on its Investor Relations website. The Company is posting the earnings release...
Find out more Haemonetics 1st Quarter Fiscal 2020 Earnings Release Available on Investor Relations Website
BRAINTREE, Mass. , Aug. 6, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its first quarter of fiscal 2020, which ended June 29, 2019 , are available on its Investor Relations website. The Company is posting the earnings release...
Find out more Haemonetics 1st Quarter Fiscal 2020 Earnings Release Available on Investor Relations Website
Recent HAE News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/20/2026 10:31:33 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 09:37:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 09:36:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 09:34:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 09:33:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 09:31:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 09:29:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 09:28:15 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/13/2026 02:40:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 10:02:40 AM
- Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website • PR Newswire (US) • 05/07/2026 10:00:00 AM
- Haemonetics to Present at Bank of America 2026 Healthcare Conference • PR Newswire (US) • 05/05/2026 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 08:18:06 PM
- New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures • PR Newswire (US) • 04/24/2026 10:20:00 AM
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026 • PR Newswire (US) • 04/01/2026 08:05:00 PM
- Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System • PR Newswire (US) • 03/30/2026 08:15:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/03/2026 11:24:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 11:09:10 AM
- Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology • PR Newswire (US) • 02/23/2026 09:15:00 PM
- Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference • PR Newswire (US) • 02/20/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2026 09:15:21 PM
- Haemonetics Tops Q3 Forecasts and Raises Fiscal 2026 Outlook • IH Market News • 02/05/2026 01:30:59 PM
